Right Turn: Holiday science gifts, real and imagined

by Stacey Johnson | Dec 8, 2023

Kudos to the clever team at Venair for coming up with the following post on their LinkedIn page: Although I’m tempted to discuss this from a public relations/marketing lens, instead I’m adding these to the list of great gift ideas for the scientist or science lover in...

Right Turn: A patient’s perspective on living through cancer, and treatment progress

by Stacey Johnson | Dec 1, 2023

Do you remember the column “Life, Interrupted” by cancer patient Suleika Jaouad? She was 22 when she was diagnosed with acute myeloid leukemia (AML) and a rare blood disorder called myelodysplastic syndrome. With her hopes to be a war correspondent on hold (dashed?),...

Overcoming the limitations of allogeneic transplants to treat incurable diseases, TMM2023

by Tyler Wenzel | Nov 23, 2023

Cell therapies that replenish a healthy cell niche have long been an attractive approach to treat a variety of diseases, such as Parkinson’s disease, which are incurable and characterized by the loss of critical cell functions. The attractiveness of cell therapies is...

HeLa Ethics: Toward a more equitable future of regenerative medicine

by Guest | Nov 17, 2023

Rebecca Ihilchik is Manager, Communications at CCRM supporting OmniaBio Inc. Drawing on a decade of experience in healthtech, non-profits, and higher education, she is most passionate about the storytelling aspect of professional communications. Rebecca holds a BA...

A bench-to-bedside story of BlueRock’s investigational stem cell therapy for Parkinson’s disease

by Kevin Robb | Nov 9, 2023

BlueRock Therapeutics has generated considerable media buzz with their announcement of positive Phase I clinical trial data on bemdaneprocel (BRT-DA01), an investigational, stem cell-derived, dopaminergic therapy for Parkinson’s disease. The trial is the result of...

Empowering women in science: Three strategies for success in academia and industry, TMM 2023

by Laine Bodnar | Nov 2, 2023

Working in science, whether in academia or industry, can be a rewarding yet challenging experience. For women pursuing careers in these fields, there are unique considerations and issues to be mindful of. As such, the Women in Science Breakfast at the 2023 Till &...

The PhD afterlife: Evaluating the postdoc as a next step

by Kevin Robb | Oct 24, 2023

It was a strange feeling, completing my PhD defense. After immersing myself for years in a highly specific research area, the months leading up to my defense felt like a storm rolling in: my mind became increasingly clouded with technical details, emerging concepts in...

The social media shift: Where scientists and engineers connect today

by Laine Bodnar | Oct 20, 2023

In today’s digital age, scientists and engineers are more interconnected than ever before, thanks to the power of social media. If you’re a scientist or engineer working in the regenerative medicine field who’s not yet using social media to engage with other...

Right Turn: Blue Rodeo is aging like the rest of us

by Stacey Johnson | Oct 13, 2023

Blue Rodeo is an iconic Canadian band that performs “countrified rock” and has been around for four decades. It has received multiple awards and accolades, including being inducted into the Canadian Music Hall of Fame, and lead singers/songwriters Jim Cuddy and Greg...

Learnings from First Nations’ traditional medicine could enhance the effectiveness of regenerative medicine

by CCRM Australia | Oct 6, 2023

This blog post was written by Jimmy Yu (see LinkedIn page) with supervision by Dr. Chih Wei Teng.  Traditional medicine and the practices of Australia’s First Nations – Australian Aboriginal people and Torres Strait Islander – embody a world imbued with ancient...